Cees Tuinenburg (M.Sc (Ir.) Biomedical Technology) is chairman of the CUP committee at the MEB. In this role he has been instrumental in the publication of the new MEB policy (MEB49) concerning the approval of Compassionate Use Programs in the Netherlands. His expertise lie in Oncology, Companion Diagnostics, Pulmonology, medicinal gasses and Compassionate Use. He has worked at the MEB as Regulatory Project Leader since 2007.